We would like to announce the availability of NIH-funded T32 HIV Research Training Funds to Harvard University available beginning July/August 2019. The goal of the program is to train both MD and PhD investigators for careers in HIV research. Potential areas of investigation include all areas of HIV/AIDS research, ranging from the laboratory to the clinic, including epidemiology, outcomes, implementation, and health policy studies. Funding is available from two Harvard T32 grants, one focused primarily on laboratory based studies (P.I. Dr. Daniel Kuritzkes) and the other on clinical...
At NIH, we are heavily invested in our workforce and in understanding the barriers they face. What characteristics do they share? How do they compete in the current hypercompetitive environment? When do they stop applying to NIH (drop out), even after receiving their first award? Staff from the National Institute of Allergy and Infectious Diseases (NIAID) delve into these questions in a paper published recently in PLOS ONE , whose findings I’d like to highlight today. Here, Drs. Patricia Haggerty and Matthew Fenton looked at factors that may contribute to the success of early-career... Read more about What Contributes to the Success of Early Career Scientists? – A NIAID Look
Authors: Viola Guardigni, MD, and Monty Montano, PhD
Although there is substantial enthusiasm for the development of HIV vaccines1,2 a remaining challenge is the treatment of people who are infected and under the care of a clinician. The introduction of effective combination antiretroviral therapy (cART) dramatically increased life expectancy in people aging with HIV (PAWH).3 In developed countries, a growing percentage of PAWH are soon to be older than 50 years, due to a longer life expectancy and to acquiring HIV infection later in life. (...
On April 27, 2017, the HU CFAR and the Ragon Institute hosted the Physician-Scientist Symposium "The role of the physician-scientist in the evolving landscape of biomedical research." Drs. Lenette Lu, Amy Barczak and Doug Kwon hosted the meeting locally with the goals of:
highlighting the excellent work by physician-scientists from around the country
exploring the variety of ways in which clinical training influences research
developing ideas of how to more completely support the careers of physician-...
HU CFAR Internal Competition-Early Stage Investigator (ESI) Call for Abstracts
Emory University is pleased to welcome Early Stage Investigators (ESIs) as participants in the Science Symposium on Thursday, November 8 and at a Mentoring Workshop on Friday, November 9 at the 2018 National CFAR Meeting...
Promising findings lead to initiation of a clinical efficacy trial in southern Africa
BOSTON - More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year.
The George Washington University School of Medicine and Health Sciences (SMHS) invites applications and nominations for the position of chair of the Department of Microbiology, Immunology, & Tropical Medicine (MITM).
The HPTN is seeking applicants for a 50% academic ID doctor to serve as a clinical trials physician for some of the major studies. This is a great opportunity for emerging investigators interested in HIV prevention research.